Global private equity firm The Carlyle Group has maintained a strong investment pace with the acquisition of an 80 percent stake in Groupe Marle, a French provider of services to the orthopaedic implant industry. Financial details were not disclosed.
Groupe Marle, which specialises in the precision forging of hip implant stems, was founded in 1978 with 11 employees. Today, it employs over 220 staff and makes more than 400,000 hip implant stems a year. The firm also forges prostheses for other body parts such as the shoulder and knee as well as ancillary medical instruments such as bone scrapers and socket holders.
Vladimir Lasocki, managing director of The Carlyle Group, said in a statement there were “strong long-term prospects” for the medical implant and equipment sectors and that Groupe Marle would be seeking to “expand into adjacent areas” as well as “follow its customers overseas, including in North America”.
The latest deal is the culmination of a busy week on the new deal front for Carlyle’s European Technology Partners, which is investing a €530 million fund closed in November.
Seven days ago, Carlyle portfolio company UC4 Software, an Austrian provider of workload automation and IT process optimisation solutions, acquired fellow Austrian company Senactive, a provider of event-driven business process modelling technology.
Two days ago, another Carlyle portfolio company also completed an add-on acquisition. Barcelona-based Applus+, a Spanish provider of testing, inspection, certification and technological services, bought Canada’s Technico, a specialist in non-destructive testing and inspections on the Canadian Atlantic seaboard. The deal was Applus+’s fourth acquisition this year.
The head of its Carlyle European Technology Partners, David Fitzgerald, resigned in May for “health reasons”. He was replaced by two co-heads: Robert Easton, a managing director who joined Carlyle in 2000 from UK engineering group Invensys; and Michael Wand, who is also a managing director and a longstanding member of the CETP team.